Nano-Pulse Stimulation (NPS) in Sebaceous Hyperplasia Optimization Study

Inclusion Criteria: * Male or Female between 18 and 75 years of age * Voluntary, written informed consent to participate in this clinical investigation and from whom consent has been obtained. * Understanding of the clinical investigation, agree to cooperate with the investigational procedures and are willing to return for all the required follow-up visits. * Understands that SHs are to be treated in a single treatment session is aware that they may receive a second treatment at their third study visit * Must be able to visit clinic site at 7-, 30-, 60-days post-primary treatment of SH lesion and at 30- and 60-days post-retreatment. * Clinically diagnosis of typical sebaceous hyperplasia. * Minimum of four SH lesions. * Undergo all study procedures including consent for photographs of the treated SH sites. * Agrees to refrain from using all other SH lesion removal products or treatments (topical medication including over-the-counter medications) during the study period. Exclusion Criteria: * Implantable electronic devices (i.e., pacemaker, implantable cardioverter defibrillator) * Active infection or history of infection in designated test area within 90 days prior to first treatment. * Not willing or able to sign the Informed Consent. * Known to be immune-compromised. * Known to be a keloid producer. * Taking blood thinning medications. * Insulin dependent, Type I diabetics. * Allergies to Lidocaine or Lidocaine-like products. * Employed by the sponsor, clinic site, or en…